Awarded contract

Purchase of 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours

  • The Royal Marsden NHS Foundation Trust

F15: Voluntary ex ante transparency notice

Notice reference: 2021/S 000-001348

Published 22 January 2021, 2:31pm



Section one: Contracting authority/entity

one.1) Name and addresses

The Royal Marsden NHS Foundation Trust

Unit G3, Harbour Yard, Chelsea Harbour

London

SW10 0XD

Contact

tenders@chelwest.nhs.uk

Email

tenders@chelwest.nhs.uk

Country

United Kingdom

NUTS code

UKI - LONDON

Internet address(es)

Main address

www.royalmarsdent.nhs.uk

Buyer's address

www.royalmarsdent.nhs.uk

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Purchase of 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours

Reference number

DN521857

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Purchase of 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £4,500,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKI - LONDON

two.2.4) Description of the procurement

The Royal Marsden Hospital NHS Foundation Trust needs to purchase 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

177Lu- Dotatate is used to treat patients with neuroendocrine tumours; currently this is the only licensed product on the market to treat this tumour and AAA is the sole distributor in the UK.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section five. Award of contract/concession

A contract/lot is awarded: Yes

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract

22 January 2021

five.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

Advanced Accelerator Application

London

Country

United Kingdom

NUTS code
  • UKI - LONDON
The contractor/concessionaire is an SME

No

five.2.4) Information on value of contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession: £4,500,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

High Court

London

Country

United Kingdom